Home > Healthcare > Pharmaceuticals > Finished Drug Form > Alexipharmic Drugs Market

Alexipharmic Drugs Market Share

  • Report ID: GMI8415
  • Published Date: Mar 2024
  • Report Format: PDF
 Download Free Sample

Alexipharmic Drugs Market Share

The alexipharmic drugs industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel drugs with improved efficiency and cost-effectiveness are among a key market strategy for alexipharmic drug manufacturers. Some of the leading industry players including Merck KGaA, Thermo Fisher Scientific Inc, Mylan N.V., and Bausch Health Companies Inc, among others have a substantial presence in the market.
 

Alexipharmic Drugs Market Companies

Some of the eminent market participants operating in the alexipharmic drugs industry include:

  • AdvaCare Pharma
  • American Regent, Inc.
  • B. Braun Melsungen AG
  • Bausch Health Companies Inc
  • Fresenius SE & Co. KGaA
  • Intelicure Lifesciences
  • Merck KGaA
  • Mylan N.V.
  • SimSon Pharma Limited
  • Thermo Fisher Scientific Inc
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Alexipharmic drugs market size was USD 3.2 billion in 2023 and is expected to register 4.8% CAGR from 2024-2032 owing to the growing usage of psychoactive substances narcotic drugs coupled with the increasing awareness regarding preventive poisoning worldwide.

Alexipharmic drugs industry from the opioid overdose segment crossed USD 1.1 billion in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to governments and regulatory bodies increasingly recognizing the severity of the opioid crisis.

North America alexipharmic drugs industry reached USD 1.3 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the presence of a robust healthcare infrastructure and extensive research & development initiatives in the region.

AdvaCare Pharma, American Regent, Inc., B. Braun Melsungen AG, Bausch Health Companies Inc, Fresenius SE & Co. KGaA, Intelicure Lifesciences, Merck KGaA, Mylan N.V., and SimSon Pharma Limited, are some of the major alexipharmic drugs companies worldwide.

Alexipharmic Drugs Market Scope

  • Alexipharmic Drugs Market Size
  • Alexipharmic Drugs Market Trends
  • Alexipharmic Drugs Market Analysis
  • Alexipharmic Drugs Market Share

    • Buy Now

    Premium Report Details

    • Base Year: 2023
    • Companies covered: 10
    • Tables & Figures: 306
    • Countries covered: 22
    • Pages: 180
     Download Free Sample
    ×
    Get a free sample of Alexipharmic Drugs Market
    Inquiry Before Buying
    Get special pricing options on this report
    Request Sectional Data
    Over 70% of our clients customize reports to fit their needs. Please tell us how you would like to customize yours below

    Your personal details will remain secure and confidential.